Key facts
- SafePAS’s last known valuation is $6.6M (Jun 2025).
- It has raised $950K.
- Notable investors include European Innovation Council, European Commission, Teamworthy Group, BSV Ventures, Beamline — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for SafePAS
- ·The full record, as it builds
Funding rounds
No funding rounds for SafePAS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SafePAS
Developer of an AI-based portable analytical sensor designed to provide rapid, accurate, and cost-effective testing for medical and agricultural needs. The company offers advanced, highly sensitive devices that deliver lab-quality quantitative analysis at significantly reduced costs, enabling healthcare providers, law enforcement agencies, and farmers to make informed decisions quickly and efficiently in diverse environments.
- Sector
- Healthcare
- HQ
- Tallinn, Estonia
- Employees
- 15
- Website
- safepas.eu/
- Ownership
- Privately Held (backing)
SafePAS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SafePAS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SafePAS in its N-PORT filings yet. We sweep new filings monthly.